Janus Henderson Group’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $518K | Sell |
|
|||||
|
2025
Q1 | $4.8M | Sell |
|
|||||
|
2024
Q4 | $7.61M | Buy |
|
|||||
|
2024
Q3 | $6.74M | Sell |
|
|||||
|
2024
Q2 | $5.38M | Sell |
|
|||||
|
2024
Q1 | $6.21M | Buy |
|
|||||
|
2023
Q4 | $538K | Sell |
|
|||||
|
2023
Q3 | $547K | Buy |
|
|||||
|
2023
Q2 | $587K | Sell |
|
|||||
|
2023
Q1 | $1.68M | Sell |
|
|||||
|
2022
Q4 | $71.2M | Sell |
|
|||||
|
2022
Q3 | $134M | Buy |
|
|||||
|
2022
Q2 | $69.5M | Sell |
|
|||||
|
2022
Q1 | $78.1M | Buy |
|
|||||
|
2021
Q4 | $65.8M | Buy |
|
|||||
|
2021
Q3 | $46.7M | Sell |
|
|||||
|
2021
Q2 | $35.6M | Buy |
|
|||||
|
2021
Q1 | $38.1M | Buy |
|
|||||
|
2020
Q4 | $39.6M | Buy |
|
|||||
|
2020
Q3 | $29.7M | Buy |
|